Trastuzumab in Combination With AMG 479 in HER-2 Overexpressing MBC Progressing on Trastuzumab

NCT01479179 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Drug sponsor decision to discontinue study.

Conditions

Breast Cancer

Interventions

DRUG: AMG 479
DRUG: Trastuzumab

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]